Metabolic GLP-1 Webinar

The Evolution of GLP-1s: Overcoming Clinical Development Challenges

Learn about the medical and operational challenges associated with the clinical development of novel glucagon-like peptide-1 (GLP-1) receptor agonists in diabetes, obesity and metabolic clinical trials. Our speakers share their insights and recommended strategies gleaned from 25+ years of clinical and research experience in diabetes and metabolic research to better equip you to successfully conduct GLP-1 studies in today’s rapidly evolving clinical landscape.

We discuss historical lessons learned and recommended solutions to specific medical and operational challenges presented in GLP-1 clinical trial delivery, including but not limited to:

• Ensuring targeted participant access, diversity and retention
• Recruitment of diabetes, obesity and metabolic disease participants in an increasingly competitive landscape
• Early withdrawals due to gastrointestinal (GI) side effects
• Lack of long-term safety data
• Justification of placebo comparators

Speakers:

• Graham Ellis, M.D., Executive Director, medical science and strategy, PPD clinical research business of Thermo Fisher Scientific
• Vijay Shivaswamy, M.D., Medical Director, pharmacovigilance, PPD clinical research business of Thermo Fisher Scientific
• Eling Gaines, Oversight Director, cardiovascular, metabolic and critical care, PPD clinical research business of Thermo Fisher Scientific
• Randall J. Severance, M.D., Director of Medical Operations, Accelerated Enrollment Solutions of part of Thermo Fisher Scientific
• Alessandra Vignola, Vice President, metabolic & liver business segment lead, PPD clinical research business of Thermo Fisher Scientific